Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Grisold, AJ; Hoenigl, M; Ovcina, I; Valentin, T; Fruhwald, S.
Ventilator-associated pneumonia caused by OXA-48-producing Escherichia coli complicated by ciprofloxacin-associated rhabdomyolysis.
J Infect Chemother. 2013; 19(6):1214-1217 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Fruhwald Sonja
Grisold Andrea
Hönigl Martin
Ovcina Ismar
Valentin Thomas
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
We report the emergence of OXA-48 carbapenemase-producing Escherichia coli in Austria causing ventilator-associated pneumonia in a traveler returning from Egypt. Depending on resistance testing, quinolones may remain a therapeutic option for infections caused by these multiple resistant pathogens, as this class of drugs has a favorable safety and tolerability profile when compared to the alternatives. In this patient, however, the clinical course was dramatically complicated by the development of ciprofloxacin-associated rhabdomyolysis.
Find related publications in this database (using NLM MeSH Indexing)
Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - therapeutic use
Ciprofloxacin - adverse effects Ciprofloxacin - therapeutic use
Escherichia coli - isolation & purification
Escherichia coli Infections - etiology Escherichia coli Infections - microbiology
Escherichia coli Proteins -
Humans -
Male -
Middle Aged -
Pneumonia, Ventilator-Associated - microbiology
Rhabdomyolysis - chemically induced Rhabdomyolysis - microbiology
beta-Lactamases -

Find related publications in this database (Keywords)
Carbapenenem resistance
OXA-48
Austria
Ciprofloxacin
Rhabdomyolysis
Escherichia coli
© Meduni Graz Impressum